Neuralink, the brain-computer interface company led by Elon MuskAnnounce, will launch a new phase of clinical trials in the United States in October, attempting to directly convert human "thoughts" into text through brain implants.
Neuralink President DJ Seo said: "If you are thinking something, we will be able to detect it and convert it into text."
The study, conducted under an Investigational Device Exemption (IDE) approved by the U.S. Food and Drug Administration, aims to help patients with speech disorders or aphasia communicate more effectively with the outside world.
Currently, many companies on the market are testing brain-computer interface technology to help patients control computers and input virtual keyboards through brain waves. Neuralink's research goes a step further, directly reading the activity of the brain's language cortex, skipping the intermediate input process. This will significantly shorten communication delays and allow patients to immediately convert their "inner thoughts" into text.
Simultaneous advancement in multiple locations around the world, targeting people with severe disabilities
Neuralink is currently conducting five clinical trials in the United States, Canada, the United Kingdom, and the United Arab Emirates. This new trial will be its sixth and the first to specifically target speech impairments. If successful, it could revolutionize the quality of life for patients with ALS (amyotrophic lateral sclerosis), stroke, and severe paralysis.
Future Vision: Healthy people can also communicate with AI "with their thoughts"
DJ Seo also revealed that Neuralink's ultimate blueprint is not limited to medical use.
The company anticipates that within three to four years, the first wave of "healthy" users will voluntarily receive Neuralink implants. This will enable direct communication with the Large Language Model (LLM) through "thought," with AI responses instantly transmitted back to the user through headphones, forming a complete "brain circuit." This means that in the future, users will be able to conduct inquiries, engage in conversations, and even control other smart devices with their thoughts, without the need for speech.
The Light and Shadow of Science Fiction
From the perspective of assisting critically ill patients, this technology is almost a sci-fi utopian vision. However, as it enters the consumer market, concerns arise. For example, mobile phones and social media algorithms are significantly changing human interactions, and the widespread use of brain-computer interfaces could further hand over human privacy, thoughts, and even behavioral patterns to technology companies.
Neuralink's clinical trials are still in the early stages, and its widespread adoption requires further validation on safety, ethics, and regulatory levels. However, as the technology continues to mature, the debate surrounding the integration of humans and technology is bound to intensify in the coming years.
